Phenolic extract of soybean (Glycine max) attenuates cisplatin-induced nephrotoxicity in rats

Food and Chemical Toxicology

Volumn 48, Issue 4, 2010, Pages 1005-1012

  Ekor, Martins ^a   Emerole, Godwin O ^a   Farombi, Ebenezer O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antioxidants; Cisplatin; Nephrotoxicity; Oxidative stress; Polyphenols soybean

Indexed keywords

5' NUCLEOTIDASE; ANTIOXIDANT; CATALASE; CISPLATIN; CREATININE; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE TRANSFERASE; GLYCINE MAX EXTRACT; MALONALDEHYDE; N ACETYL BETA GLUCOSAMINIDASE; NITRATE; NITRITE; PHENOL; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; LIVER HISTOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; SOYBEAN;

5'-NUCLEOTIDASE; ACETYLGLUCOSAMINIDASE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; DISEASE MODELS, ANIMAL; GLUCOSE-6-PHOSPHATASE; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALONDIALDEHYDE; NITRATES; NITRITES; OXIDOREDUCTASES; PEROXIDASE; PHENOL; PLANT EXTRACTS; RATS; RATS, WISTAR; SOYBEANS;

ANIMALIA; GLYCINE MAX; RATTUS;

EID: 77549086358     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.12.027     Document Type: Article

References (77)

1. Arany I., and Safirstein R.L. Cisplatin nephrotoxicity. Semin. Nephrol. 23 (2003) 460-464
2. Barnes S., Grubbs C., Setchell K.D.R., and Carlson J. Soybean inhibits mammary tumours in models of breast cancer. Mutagens and Carcinogens in the diet (1990), Wiley-Liss pp. 239-253
3. Baylis C., and Qin C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int. 49 (1996) 1727-1731
4. Beutler E., Duron O., and Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61 (1963) 882-888
5. Bonventre J.V. Pathophysiology of ischemic acute renal failure. Inflammation, lung-kidney cross-talk and biomarkers. Contrib. Nephrol. 144 (2004) 19-30
6. Borrego A., Zamora Z.B., Gonzalez R., Romay C., Menedez S., Hernandez F., Montero T., and Rojas E. Protection by ozone pre-conditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediat. Inflamm. 13 1 (2004) 13-19
7. Braca A., Sortino C., Politi M., Morelli I., and Mendez J. Antioxidant activity of flavonoids from Licania licaniaeflora. J. Ethnopharmacol. 79 (2002) 379-381
8. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108 (2001) 1283-1290
9. Cavin A., Hostettmann K., Dyatmyko W., and Potterat O. Antioxidant and lipophilic constituents of Tinospora crispa. Planta Med. 64 (1998) 393-396
10. Chirino Y., and Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 61 (2009) 223-242
11. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36 (1990) 1440-1443
12. Davis C.A., Nick H.S., and Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J. Am. Soc. Nephrol. 12 (2001) 2683-2690
13. Dickey D.T., Wu Y.J., Muldoon L.L., and Neuwelt E.A. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular and in vivo levels. J. Pharmacol. Exp. Ther. 314 3 (2005) 1052-1058
14. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., and Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
15. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide inflammatory oxidant by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
16. Ekor M., Farombi E.O., and Emerole G.O. Modulation of gentamicin-induced renal dysfunction and injury by the phenolic extract of soybean (Glycine max). Fundam. Clin. Pharmacol. 20 (2006) 263-271
17. Friedewald J.J., and Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 66 (2004) 486-491
18. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., and Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. J. Clin. Invest. 109 (2000) 1311-1319
19. Gille J.J., van Berkel C.G., and Joenje H. Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis 15 (1994) 2695-2699
20. Gonzalez R., Borrego A., Zamora Z., Romay C., Hernandez F., Menendez S., Montero T., and Rojas E. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediat. Inflamm. 13 5/6 (2004) 307-312
21. Goodland G.A.J., and Clark C.M. Alteration in hepatic 5′-nuceotidase in the tumor bearing rat. Enzyme 27 (1982) 119-123
22. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177 (1949) 751
23. Gulec M., Iraz M., Yilmaz H.R., Ozyurt H., and Temel I. The effects of Ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde and nitric oxide in cisplatin-induced nephrotoxicity. Toxicol. Ind. Health 22 3 (2006) 125-130
24. Habig W.H., Pabst M.J., and Jacoby W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
25. Hara M., Yoshida M., Nishijima H., Yokosuka M., Iigo M., Ohtani K.R., Shimada A., Hasegawa T., Akama Y., and Hirata K. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. J. Pineal Res. 30 (2001) 129-138
26. Hughes A.K., Strcklett K., Padilla E., and Kohan D.E. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney Int. 49 (1996) 181-189
27. Ikari A., Nagatani Y., Tsukimoto M., Harada H., Miwa M., and Takagi K. Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochim. Biophys. Acta 1717 2 (2005) 109-117
28. Jones E.E., and Shoskes D.A. The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair. J. Urol. 163 (2000) 999-1004
29. Kadikoylu G., Bolaman Z., Demir S., Balkaya M., Akalin N., and Enli Y. The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum. Exp. Toxicol. 23 (2004) 29-34
30. Knight D.C., and Eden J.A. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87 (1996) 897-904
31. Kuhlman M.K., Burkhardt G., and Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 12 (1997) 2478-2480
32. Lebwohl D., and Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer 34 (1998) 1522-1534
33. Lee S., Kim W., Moon S.-O., Sung M.J., Kim D.H., Kang K.P., Jang Y.B., Lee J.E., Jang K.Y., and Park S.K. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol. Dial. Transplant. 21 (2006) 2096-2105
34. Leonard B.J., Eccleston E., Jones D., Todd P., and Walpole A. Anti-leukemic and nephrotoxic properties of platinum compounds. Nature 234 (1971) 43-45
35. Li S., Gokden N., Okusa M.D., Bhatt R., and Portilla D. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am. J. Physiol. Renal Physiol. 289 (2005) F469-F480
36. Lieberthal W., Triaca V., and Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs necrosis. Am. J. Physiol. 270 4 Pt. 2 (1996) F700-F708
37. Liu M., Chien C.-C., Burne-Taney M., Molls R.R., Racusen L.C., Colvin R.B., and Rabb H. A pathophysiologic role for T lymphocytes in Murine acute cisplatin nephrotoxicity. J. Am. Soc. Nephrol. 17 (2006) 765-774
38. Lu L.H., Oh D.-H., Dursun B., He Z., Hoke T.S., Faubel S., and Edelstein C.L. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 324 (2008) 111-117
39. Luke D.R., Vadiel K., and Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol. Dial. Transplant. 7 (1992) 1-7
40. Messina M.J., Persky V., Setchell K.D.R., and Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 21 (1994) 113-131
41. Misra H.P., and Fridovich I. The univalent reduction of oxygen by reduced flavins and quinines. J. Biol. Chem. 247 (1972) 188-192
42. Navarro-Gonzalvez J.A., Garcia-Benayas C., and Arenas J. Semi-automated measurement of nitrate in biological fluids. Clin. Chem. 44 3 (1998) 679-681
43. Nourooz-Zadeh J., Tajaddini-Sarmadi J., and Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220 2 (1994) 403-409
44. Okusa M.D. The inflammatory cascade in acute ischemic renal failure. Nephron 90 (2002) 133-138
45. Pabla N., and Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73 (2008) 994-1007
46. Pan H., Mukhopadhyay P., Rajesh M., Patel V., Mukhopadhyay B., Gao B., Hasko G., and Pacher P. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation and cell death. J. Pharmacol. Exp. Ther. 328 (2009) 708-714
47. Parks D.A., Williams T.K., and Beckman J. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine. A re-evaluation. Am. J. Physiol. 254 (1988) G768-G774
48. Prichard M., Ducharme N.G., Wilkins P.A., Erb H.N., and Butt M. Xanthine oxidase formation during experimental ischemia of the equine small intestine. Can. J. Vet. Res. 55 (1991) 310-314
49. Rabik C.A., and Dolan M.E. Molecular mechanisms and toxicity associated with platinating agents. Cancer Treat. Rev. 33 1 (2007) 9-23
50. Ramesh G., and Reeves W.B. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110 (2002) 835-842
51. Ramesh G., and Reeves W.B. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am. J. Physiol. Renal Physiol. 285 (2003) F610-F618
52. Ramesh G., and Reeves W.B. P38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am. J. Physiol. Renal Physiol. 289 (2005) F116-F174
53. Ramesh G., and Reeves W.B. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumour necrosis factor- α. Kidney Int. 65 (2004) 490-498
54. Ranich T., Bhathena S.J., and Velasquez M.T. Protective effects of dietary phytoestrogens in chronic renal disease. J. Ren. Nutr. 11 (2001) 183-193
55. Ries F., and Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am. J. Kidney Dis. 8 (1986) 368-379
56. Rudin C.M., Yang Z., Schumaker L.M., VanderWeele D.J., Newkirk K., Egorin M.J., Zuhowski E.G., and Cullen K.J. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res. 63 2 (2003) 312-318
57. Saad S.Y., and Al-Rikabi A.C. Protective effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 48 1 (2002) 42-48
58. Satoh M., Kashihara N., Fujimoto S., Horike H., Tokura T., Namikoshi T., Sasaki T., and Makino H. A novel free radical scavenger, edaraborne, protects against cisplatin-induced acute renal damage in vitro and in vivo. J. Pharmacol. Exp. Ther. 305 (2003) 1183-1190
59. Schrier R.W. Cancer therapy and renal injury. J. Clin. Invest. 100 (2002) 743-745
60. Sener G., Satiroglu H., Kabasakal L., Arbak S., Oner S., Ercan F., and Keyer-Uysa M. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam. Clin. Pharmacol. 14 (2000) 553-560
61. Shino Y., Itoh Y., Kubota T., Yano T., Sendo T., and Oishi R. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PKI cells. Free Radical Biol. Med. 35 (2003) 966-977
62. Singha A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394
63. Somani S.M., Husain K., Whitworth C., Trammel G.L., Malafa M., and Rybak L.P. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol. Toxicol. 86 5 (2000) 234-241
64. Stadtman E.R. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radical Biol. Med. 9 (1990) 315-325
65. Star R.A. Treatment of acute renal failure. Kidney Int. 54 (1998) 1817-1831
66. Swanson M. Glucose-6-phosphatase from rat liver. Methods Enzymol. 2 (1955) 541-543
67. Teixeria R.B., Kelly J., Alpert H., Pardo V., and Vaamonde C.A. Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. Kidney Int. 21 (1982) 600-612
68. Thadhani R., Pascual M., and Bonventre J.V. Medical progress - acute renal failure. N. Engl. J. Med. 334 (1996) 1448-1460
69. Tsuruya K., Tokumoto M., Ninomiya T., Hirakawa M., Masutani K., Taniguchi M., Fukuda K., Kanai H., Hirakata H., and Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am. J. Physiol. Renal Physiol. 285 (2003) F208-F218
70. Varshney R., and Kale R.K. Effect of calmodulin antagonist on radiation induced lipid peroxidation in microsomes. Int. J. Radiat. Biol. 58 (1990) 733-743
71. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone, Genistein. P.E.S.B 208 (1995) 124-130
72. Weijl N.I., Elsendoorn T.J., Lentjes E.G., Hopman G.D., Wipkin-Bakker A., Zwinderman A.H., Cleton F.J., and Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double blind, placebo-controlled study. Eur. J. Cancer 40 (2004) 1713-1723
73. Winston J.A., and Safirstein R. Reduced renal blood floe in early cisplatin-induced acute renal failure in rat. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 249 (1985) F490-F496
74. Winterbourn C.C., Vissers M.C., and Kettle A.J. Myeloperoxidase. Curr. Opin. Hematol. 7 (2000) 53-58
75. Yilmaz H.R., Iraz M., Sogut S., Ozyurt H., Yildirim Z., Akyol O., and Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 50 (2004) 287-290
76. Zhang B., Ramesh G., Uematsu S., Akira S., and Reeves W.B. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J. Am. Soc. Nephrol. 19 (2008) 923-932
77. Zhou H., Kato A., Miyayi T., Yasuda H., Fujigaki Y., Yamamoto T., Yonemura K., Takebayashi S., Mineta H., and Hishida A. Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol. Dial. Transplant. 21 (2006) 616-623